Literature DB >> 22050281

Excessive resections in breast-conserving surgery: a retrospective multicentre study.

Nicole Krekel1, Barbara Zonderhuis, Sandra Muller, Herman Bril, Henk-Jan van Slooten, Elly de Lange de Klerk, Petrousjka van den Tol, Sybren Meijer.   

Abstract

The main determinant of cosmetic outcomes following breast-conserving surgery (BCS) for breast cancer is the volume of resection. The importance of achieving optimal oncological control may lead to an unnecessarily large resection of breast tissue. The aim of this study is to evaluate excess resection volume in BCS for cancer by determining a calculated resection ratio (CRR). This retrospective study was conducted in four affiliated institutions and involved 726 consecutive patients with T1-T2 invasive breast cancer treated by BCS between January 2006 and 2009. The pathology reports were reviewed for tumor palpability, tumor size, surgical specimen size, and oncological margin status. The optimal resection volume (ORV) was defined as the spherical tumor volume with an added 1.0 cm margin of healthy breast tissue. The total resection volume (TRV) was defined as the ellipsoid volume of the surgical specimen. CRR was determined by dividing the TRV by the ORV. Of all tumors, 72% (525/726) were palpable, and 28% (201/726) were nonpalpable. The tumor stage was T1 in 492 patients (67.8%) and T2 in 234 patients (32.2%). The median CRR was 2.5 (0.01-42.93). Margin status was positive or focally positive in 153 patients (21.1%). Lower tumor stage was associated with a higher CRR (factor 0.61 [p < 0.0001] and a lower positive margin rate [p = 0.064]). Accordingly, the median CRR of the nonpalpable lesions was higher than that of the palpable lesions (3.1 and 2.2, respectively; p < 0.01), and the involved margin rate was lower (17.4% and 22.5%, respectively; p = 0.13). Of patients with a CRR >4.0, 10.7% still had tumor involved margins. This study clearly shows that BCS is associated with excessive resection of healthy breast tissue while clear margins are not assured. Surgical factors should be modified to improve surgical accuracy.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22050281     DOI: 10.1111/j.1524-4741.2011.01198.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  16 in total

1.  Endoscopic axillary lymphadenectomy combined with laparoscopically harvested pedicled omentum for immediate breast reconstruction.

Authors:  Pusheng Zhang; Yunfeng Luo; Jianwen Deng; Guoli Shao; Shuai Han; Zonghai Huang
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

2.  Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells.

Authors:  Alexander Liberman; Zhe Wu; Christopher V Barback; Robert Viveros; Sarah L Blair; Lesley G Ellies; David R Vera; Robert F Mattrey; Andrew C Kummel; William C Trogler
Journal:  ACS Nano       Date:  2013-07-01       Impact factor: 15.881

3.  Intraoperative ultrasound guided breast surgery: paving the way for personalized surgery.

Authors:  Martin Espinosa-Bravo; Isabel T Rubio
Journal:  Gland Surg       Date:  2016-06

Review 4.  Innovations in image-guided preoperative breast lesion localization.

Authors:  Ellen Cheang; Richard Ha; Cynthia M Thornton; Victoria L Mango
Journal:  Br J Radiol       Date:  2018-02-06       Impact factor: 3.039

5.  Use of Intraoperative Ultrasound During Breast Conservation Surgery (BCS) for Palpable Breast Cancer: an Extremely Effective Approach with Improved Oncological Outcome.

Authors:  Tanay Shah; Arvind Thakuria; Parth Patel; Sanjeev Patni; Sushma Mahajan; Shashikant Saini
Journal:  Indian J Surg Oncol       Date:  2019-05-23

Review 6.  Current status of ultrasound-guided surgery in the treatment of breast cancer.

Authors:  José H Volders; Max H Haloua; Nicole Ma Krekel; Sybren Meijer; Petrousjka M van den Tol
Journal:  World J Clin Oncol       Date:  2016-02-10

7.  Intraoperative Ultrasound in the Treatment of Breast Cancer.

Authors:  H Eggemann; T Ignatov; A Beni; S D Costa; O Ortmann; A Ignatov
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-10       Impact factor: 2.915

8.  Tissue-simulating phantoms for assessing potential near-infrared fluorescence imaging applications in breast cancer surgery.

Authors:  Rick Pleijhuis; Arwin Timmermans; Johannes De Jong; Esther De Boer; Vasilis Ntziachristos; Gooitzen Van Dam
Journal:  J Vis Exp       Date:  2014-09-19       Impact factor: 1.355

9.  Ultrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life. A prospective multicentre randomised controlled clinical trial comparing ultrasound-guided surgery to traditional palpation-guided surgery (COBALT trial).

Authors:  Nicole M A Krekel; Barbara M Zonderhuis; Hermien W H Schreurs; Alexander M F Lopes Cardozo; Herman Rijna; Henk van der Veen; Sandra Muller; Pieter Poortman; Louise de Widt; Wilfred K de Roos; Anne Marie Bosch; Annette H M Taets van Amerongen; Elisabeth Bergers; Mecheline H M van der Linden; Elly S M de Lange de Klerk; Henri A H Winters; Sybren Meijer; Petrousjka M P van den Tol
Journal:  BMC Surg       Date:  2011-03-16       Impact factor: 2.102

10.  Intraoperative ultrasound reduces the need for re-excision in breast-conserving surgery.

Authors:  Hasan Karanlik; Ilker Ozgur; Dilek Sahin; Merdan Fayda; Semen Onder; Ekrem Yavuz
Journal:  World J Surg Oncol       Date:  2015-11-24       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.